Molecular effects of lapatinib in patients with HER2 positive ductal carcinoma in situ

INTRODUCTION: Human epidermal growth factor receptor 2 (HER2) amplification is frequent in ductal carcinoma in situ (DCIS) of the breast and is associated with poorly differentiated tumors and adverse prognosis features. This study aimed to determine the molecular effects of the HER2 inhibitor lapat...

Descripción completa

Detalles Bibliográficos
Autores principales: Estévez, Laura G, Suarez-Gauthier, Ana, García, Elena, Miró, Cristina, Calvo, Isabel, Fernández-Abad, María, Herrero, Mercedes, Marcos, Manuel, Márquez, Cristina, Lopez Ríos, Fernando, Perea, Sofía, Hidalgo, Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4448559/
https://www.ncbi.nlm.nih.gov/pubmed/25186428
http://dx.doi.org/10.1186/bcr3695

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4448559/
https://www.ncbi.nlm.nih.gov/pubmed/25186428
http://dx.doi.org/10.1186/bcr3695

Ejemplares similares